Trophic action of sphingosine 1-phosphate in denervated rat soleus muscle

American Journal of Physiology - Cell Physiology

Volumn 294, Issue 1, 2008, Pages

  Zanin, Marika ^a   Germinario, Elena ^a,b   Dalla Libera, Luciano ^c   Sandonà, Dorianna ^a   Sabbadini, Roger A ^d   Betto, Romeo ^b,c   Danieli Betto, Daniela ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b Interuniversity Institute of Myology of Italy   (Italy)

^c CNR   (Italy)

^d SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

Skeletal muscle atrophy; Sphingomyelin derivatives; Sphingosine 1 phosphate receptors

Indexed keywords

MYOD PROTEIN; MYOGENIN; N,N DIMETHYLSPHINGOSINE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE 3 PHOSPHATE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DENERVATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOFLUORESCENCE; MALE; MOTOR NERVE; MOUSE; MUSCLE FUNCTION; NEUROMUSCULAR SYNAPSE; NONHUMAN; OSMOTIC PUMP; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; SOLEUS MUSCLE; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ANIMALS; ANTIBODIES; CELL ENLARGEMENT; CELL MEMBRANE; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; HYPERTROPHY; INFUSION PUMPS, IMPLANTABLE; LYSOPHOSPHOLIPIDS; MALE; MUSCLE DENERVATION; MUSCLE, SKELETAL; MUSCULAR ATROPHY; MYOD PROTEIN; MYOGENIN; MYOSIN HEAVY CHAINS; NEUROMUSCULAR JUNCTION; NUCLEAR ENVELOPE; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RATS; RATS, WISTAR; RECEPTORS, LYSOSPHINGOLIPID; RNA, MESSENGER; SCIATIC NERVE; SPHINGOSINE; TIME FACTORS;

RATTUS;

EID: 38349119980     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00164.2007     Document Type: Article

References (60)

1. Andrieu-Abadie N, Levade T. Sphingomyelin hydrolysis during apoptosis. Biochim Biophys Acta 1585: 126-134, 2002.
2. Aoki S, Yatomi Y, Ohta M, Osada M, Kazama F, Satoh K, Nakahara K, Ozaki Y. Sphingosine 1-phosphate-related metabolism in the blood vessel. J Biochem (Tokyo) 138: 47-55, 2005.
3. Bencini C, Squecco R, Piperio C, Formigli L, Meacci E, Nosi D, Tiribilli B, Vassalli M, Quercioli F, Bruni P, Zecchi Orlandini S, Francini F. Effects of sphingosine 1-phosphate on excitation-contraction coupling in mammalian skeletal muscle. J Muscle Res Cell Motil 24: 539-554, 2003.
4. Betto R, Teresi A, Duca M, Turcato F, Danieli-Betto D, Sabbadini RA. Inability of sphingosine and calmodulin to control ryanodine receptor in malignant hyperthermia. Basic Appl Myol 12: 159-167, 2002.
5. Borisov AB, Carlson BM. Cell death in denervated skeletal muscle is distinct from classical apoptosis. Anat Rec 258: 305-318, 2000.
6. Borisov AB, Dedkov EI, Carlson BM. Interrelations of myogenic response, progressive atrophy of muscle fibers, and cell death in denervated skeletal muscle. Anat Rec 264: 203-218, 2001.
7. Brailoiu E, Cooper RL, Dun NJ. Sphingosine 1-phosphate enhances spontaneous transmitter release at the frog neuromuscular Junction. Br J Pharmacol 136: 1093-1097, 2002.
8. Cavalli AL, Ligutti JA, Gellings NM, Castro E, Page MT, Klepper RE, Sabbadini RA. The role of TNFα and sphingolipid signaling in cardiac hypoxia: evidence that cardiomyocytes release TNFα and sphingosine. Basic Appl Myol 12: 167-176, 2002.
9. Chun J, Goetzl EJ, Hla T, Igarashi Y, Lynch KR, Moolenaar W, Pyne S, Tigyi G. International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature. Pharmacol Rev 54: 265-269, 2002.
10. Colombaioni L, Garcia-Gil M. Sphingolipid metabolites in neural signalling and function. Brain Res Brain Res Rev 46: 328-355, 2004.
11. Cuvillier O, Pirianov G, Kleuser B, Vanek PG, Coso OA, Gutkind S, Spiegel S. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381: 800-803, 1996.
12. Dalla Libera L, Sabbadini RA, Renken C, Ravara B, Sandri M, Betto R, Angelini A, Vescovo G. Apoptosis in the skeletal muscle of rats with heart failure is associated with increased serum levels of TNFα and sphingosine. J Mol Cell Cardiol 33, 1871-1878, 2001.
13. Danieli-Betto D, Germinario E, Esposito A, Megighian A, Midrio M, Ravara B, Damiani E, Libera LD, Sabbadini RA, Betto R. Sphingosine 1-phosphate protects mouse extensor digitorum longus skeletal muscle during fatigue. Am J Physiol Cell Physiol 288: C1367-C1373, 2005.
14. Danieli-Betto D, Germinario E, Esposito A, Sandonà D, Martinello T, Jakubiec-Puka A, Biral D, Betto R. Deficiency of α-sarcoglycan differently affects fast- and slow-twitch skeletal muscles. Am J Physiol Regul Integr Comp Physiol 289: R1328-R1337, 2005.
15. Day CS, Buranapanitkit B, Riano FA, Tomaino MM, Somogyi G, Sotereanos DG, Kuroda R, Huard J. Insulin growth factor-1 decreases muscle atrophy following denervation. Microsurgery 22: 144-151, 2002.
16. Deutschman DH, Carstens JS, Klepper RL, Smith WS, Page MT, Young TR, Gleason LA, Nakajima N, Sabbadini RA. Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate. Am Heart J 146: 62-68, 2003.
17. Dobrzyn A, Zendzian-Piotrowska M, Gorski J. Effect of endurance training on the sphingomyelin-signalling pathway activity in the skeletal muscles of the rat. J Physiol Pharmacol 55: 305-313, 2004.
18. 2+ transients and cytoskeletal rearrangement in C2C12 myoblastic cells. Am J Physiol Cell Physiol 282: C1361-C1373, 2002.
19. Germinario E, Esposito A, Megighian A, Midrio M, Biral D, Betto R, Danieli-Betto D. Early changes of sarcoplasmic reticulum and myofibrillar properties of type 2B fibers after denervation of rat EDL skeletal muscle. J Appl Physiol 92: 2045-2053, 2002.
20. 2+-ATPase slow (SERCA2) isoform in regenerating rat soleus skeletal muscle depends on nerve impulses. Exp Physiol 87: 575-583, 2002.
21. Glass DJ. Skeletal muscle hypertrophy and atrophy signaling pathways. Int J Biochem Cell Biol 37: 1974-1984, 2005.
22. Goldspink G. Mechanical signals, IGF-1 gene splicing, and muscle adaptation. Physiology (Bethesda) 20: 232-238, 2005.
23. Hait NC, Oskeritzian CA, Paugh SW, Milstien S, Spiegel S. Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. Biochim Biophys Acta 1758: 2016-2026, 2006.
24. Huang S, Wang F, Hong G, Wan S, Kang H. Protective effects of ciliary neurotrophic factor on denervated skeletal muscle. J Huazhong Univ Sci Technolog Med Sci 22: 148-151, 2002.
25. Huey KA, Bodine SC. Changes in myosin mRNA and protein expression in denervated rat soleus and tibialis anterior. Eur J Biochem 256: 45-50, 1998.
26. Hyatt JP, Roy RR, Baldwin KM, Wernig A, Edgerton VR. Activity-unrelated neural control of myogenic factors in a slow muscle. Muscle Nerve 33: 49-60, 2006.
27. Ishido M, Kami K, Masuhara M. In vivo expression patterns of MyoD, p21, and Rb proteins in myonuclei and satellite cells of denervated rat skeletal muscle. Am J Physiol Cell Physiol 287: C484-C493, 2004.
28. Jackman RW, Kandarian SC. The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol 287: C834-C843, 2004.
29. Jejurikar SS, Kuzon WM Jr. Satellite cell depletion in degenerative skeletal muscle. Apoptosis 8: 573-578, 2003.
30. Johnson KR, Becker KP, Facchinetti MM, Hannun YA, Obeid LM. KC-dependent activation of sphingosine kinase 1 and translocation to the plasma membrane. Extracellular release of sphingosine-1-phosphate induced by phorbol 12-myristate 13-acetate (PMA). J Biol Chem 277: 35257-35262, 2002.
31. Liliom K, Sun G, Bunemann M, Virag T, Nusser N, Baker DL, Wang DA, Fabian MJ, Brandts B, Bender K, Eickel A, Malik KU, Miller DD, Desiderio DM, Tigyi G, Pott L. Sphingosylphosphorylcholine is a naturally occurring lipid mediator in blood plasma: a possible role in regulating cardiac function via sphingolipid receptors. Biochem J 355: 189-197, 2001.
32. Maceyka M, Payne SG, Milstien S, Spiegel S. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim Biophys Acta 1585: 193-201, 2002.
33. McCullagh KJ, Calabria E, Pallafacchina G, Ciciliot S, Serrano AL, Argentini C, Kalhovde JM, Lomo T, Schiaffino S. NFAT is a nerve activity sensor in skeletal muscle and controls activity-dependent myosin switching. Proc Natl Acad Sci USA 101: 10590-10595, 2004.
34. 12 myoblasts via Edg3 and Edg5 receptors. Biochem J 362: 349-357, 2002.
35. 12 myoblasts. Biochem J 381: 655-663, 2004.
36. Megighian M, Germinario E, Rossini K, Midrio M, Danieli-Betto D. Nerve control of type MHC isoform expression in regenerating slow skeletal muscle. Muscle Nerve 24: 47-53, 2001.
37. Midrio M, Danieli-Betto D, Megighian A, Betto R. Early effects of denervation on sarcoplasmic reticulum properties of slow-twitch rat muscle fibers. Pflügers Arch 434: 398-405, 1997.
38. Midrio M. The denervated muscle: facts and hypotheses. A historical review. Eur J Appl Physiol 98: 1-21, 2006.
39. Murata N, Sato K, Kon J, Tomura H, Yanagita M, Kuwabara A, Ui M, Okajima F. Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. Biochem J 352: 809-815, 2000.
40. Nagata Y, Partridge TA, Matsuda R, Zammit PS. Entry of muscle satellite cells into the cell cycle requires sphingolipid signaling. J Cell Biol 174: 245-253, 2006.
41. Nakajima N, Cavalli AL, Biral D, Glembotski CC, McDonough PM, Ho PD, Betto R, Sandona D, Palade PT, Dettbarn CA, Klepper RE, Sabbadini RA. Expression and characterization of Edg-1 receptors in rat cardiomyocytes: calcium deregulation in response to sphingosine 1-phosphate. Eur J Biochem 267: 5679-5686, 2000.
42. Nava VE, Lacana E, Poulton S, Liu H, Sugiura M, Kono K, Milstien S, Kohama T, Spiegel S. Functional characterization of human sphingosine kinase-1. FEBS Lett 473: 81-84, 2000.
43. Ohta H, Sweeney EA, Masamune A, Yatomi Y, Hakomori S, Igarashi Y. Induction of apoptosis by sphingosine in human leukemic HL-60 cells: a possible endogenous modulator of apoptotic DNA fragmentation occurring during phorbol ester-induced differentiation. Cancer Res 55: 691-697, 1995.
44. Olivera A, Rosenfeldt HS, Bektas M, Wang F, Ishii I, Chun J, Milstien S, Spiegel S. Sphingosine kinase type 1 induces G12/13-mediated stress fiber formation, yet promotes growth and survival independent of G protein coupled receptors. J Biol Chem 278: 46452-46460, 2003.
45. Pyne S, Pyne NJ. Sphingosine 1-phosphate signalling in mammalian cells. Biochem J 349: 385-402, 2000.
46. Raffaello A, Laveder P, Romualdi C, Bean C, Toniolo L, Germinario E, Megighian A, Danieli-Betto D, Reggiani C, Lanfranchi G. Denervation in murine fast-twitch muscle: short term physiological changes and temporal expression profiling. Physiol Genomics 25: 60-74, 2006.
47. Robert P, Tsui P, Laville MP, Livi GP, Sarau HM, Bril A, Berrebi-Bertrand I. EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes. J Mol Cell Cardiol 33: 1589-1606, 2001.
48. Sabbadini RA, Danieli-Betto D, Betto R. The role of sphingolipids in the control of skeletal muscle function: a review. Ital J Neurol Sci 20: 423-430, 1999.
49. Sabbadini RA, McNutt W, Jenkins G, Betto R, Salviati G. Sphingosine is endogenous to cardiac and skeletal muscle. Biochem Biophys Res Commun 193: 752-758, 1993.
50. Sandri M, Carraro U. Apoptosis of skeletal muscles during development and disease. Int J Biochem Cell Biol 31: 1373-1390, 1999.
51. Shavlakadze T, White JD, Davies M, Hoh JF, Grounds MD. Insulin-like growth factor I slows the rate of denervation induced skeletal muscle atrophy. Neuromuscul Disord 15: 139-46, 2005.
52. Spiegel S, Milstien S. Sphingosine 1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 4: 397-407, 2003.
53. Sweeney EA, Sakakura C, Shirahama T, Masamune A, Ohta H, Hakomori S, Igarashi Y. Sphingosine and its methylated derivative N,N-dimethylsphingosine (DMS) induce apoptosis in a variety of human cancer cell lines. Int J Cancer 66: 358-366, 1996.
54. Talmadge RJ, Roy RR. Electrophoretic separation of rat skeletal muscle myosin heavy-chain isoforms. J Appl Physiol 75: 2337-2340, 1993.
55. Tews DS. Muscle-fiber apoptosis in neuromuscular diseases. Muscle Nerve 32: 443-458, 2005.
56. Toman RE, Spiegel S. Lysophospholipid receptors in the nervous system. Neurochem Res 27: 619-627, 2002.
57. Visentin B, Vekich JA, Sibbald BJ, Cavalli AL, Moreno KM, Matteo RG, Garland WA, Lu Y, Yu S, Hall HS, Kundra V, Mills GB, Sabbadini RA. Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell 9: 225-238, 2006.
58. Yatomi Y, Ruan F, Megidish T, Toyokuni T, Hakomori S, Igarashi Y. N,N dimethylsphingosine inhibition of sphingosine kinase and sphingosine 1-phosphate activity in human platelets. Biochemistry 35: 626-633, 1996.
59. Yatomi Y, Yamamura S, Ruan F, Igarashi Y. Sphingosine-1-phosphate induces platelet activation through an extracellular action and shares a platelet surface receptor with lysophosphatidic acid. J Biol Chem 272: 5291-5297, 1997.
60. Zhang G, Contos JJA, Weiner JA, Fukushima N, Chun J. Comparative analysis of three murine G-protein coupled receptors activated by sphingosine-1-phosphate. Gene 227: 89-99, 1999.